CINECA IRIS Institutional Research Information System

CARULLO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.047
AS - Asia 1.008
EU - Europa 451
SA - Sud America 115
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 34
Totale 2.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.008
SG - Singapore 391
CN - Cina 271
IT - Italia 185
HK - Hong Kong 110
BR - Brasile 94
VN - Vietnam 64
DE - Germania 63
KR - Corea 50
GB - Regno Unito 35
FR - Francia 32
FI - Finlandia 31
SE - Svezia 31
IN - India 29
JP - Giappone 29
CA - Canada 13
NL - Olanda 13
BD - Bangladesh 11
PL - Polonia 10
RU - Federazione Russa 10
AT - Austria 9
CI - Costa d'Avorio 9
MX - Messico 9
ID - Indonesia 8
ES - Italia 7
SN - Senegal 7
TR - Turchia 6
UA - Ucraina 6
VE - Venezuela 6
AR - Argentina 5
IQ - Iraq 5
LT - Lituania 5
UZ - Uzbekistan 5
PK - Pakistan 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
KE - Kenya 3
MA - Marocco 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
JO - Giordania 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MQ - Martinica 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 2.657
Salva come PNG Salva come JPEG
Città #
Singapore 258
Ashburn 228
San Jose 192
Hong Kong 108
Dallas 93
Santa Clara 85
Hefei 75
Seoul 46
Shanghai 41
Los Angeles 39
Munich 36
Beijing 35
Council Bluffs 34
New York 27
Tokyo 27
Ho Chi Minh City 26
Boardman 20
Turku 20
Florence 18
Hanoi 18
Columbus 16
Milan 16
Pisa 16
London 15
Redondo Beach 15
Frankfurt am Main 12
Abidjan 9
Genoa 9
Helsinki 9
São Paulo 9
Lauterbourg 8
Warsaw 8
Washington 8
Dakar 7
Orem 7
Phoenix 7
Rome 7
Turin 7
Cascina 6
Hyderabad 6
Mumbai 6
Nuremberg 6
Buffalo 5
Chicago 5
Denver 5
Fuzhou 5
Manchester 5
Ogden 5
Quanzhou 5
Vienna 5
Atlanta 4
Avaré 4
Bologna 4
Guarulhos 4
Jakarta 4
Salerno 4
Amsterdam 3
Bexley 3
Brooklyn 3
Da Nang 3
Haiphong 3
Istanbul 3
Managua 3
Nam-gu 3
Ottawa 3
Philadelphia 3
Poplar 3
San José 3
Stockholm 3
Tashkent 3
Abingdon 2
Alexandria 2
Amparo 2
Araure 2
Baku 2
Bangkok 2
Bari 2
Barquisimeto 2
Basra 2
Biên Hòa 2
Castelvetro di Modena 2
Castiglione Chiavarese 2
Castiglione delle Stiviere 2
Center 2
Cesena 2
Chennai 2
Chongqing 2
Colombo 2
Dammam 2
Dehradun 2
Dhaka 2
Düsseldorf 2
Falkenstein 2
Fano 2
Guangzhou 2
Houston 2
Jersey City 2
Karachi 2
Kyiv 2
Las Vegas 2
Totale 1.801
Salva come PNG Salva come JPEG
Nome #
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials 187
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability 186
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 170
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials 155
Surgery combined with intra-operative microwaves ablation for the management of colorectal cancer liver metastasis: A case-matched analysis and evaluation of recurrences 154
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm 130
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients 128
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials 128
The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies 125
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer 112
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study 110
Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal Cancer 107
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study 106
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 103
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 102
ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer 98
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials 88
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies 86
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 82
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden 79
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 66
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 43
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study 37
null 35
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study 33
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment 33
null 15
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 8
Totale 2.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202352 0 0 0 0 0 15 0 2 22 0 12 1
2023/2024186 6 10 18 9 19 24 26 4 12 13 24 21
2024/2025807 18 26 13 33 52 63 53 43 83 71 136 216
2025/20261.456 136 160 117 115 136 90 227 107 78 132 119 39
2026/2027205 113 64 28 0 0 0 0 0 0 0 0 0
Totale 2.706